The art and science of switching antipsychotic medications, part 2.

Peter J. Weiden, Alexander L. Miller, Tim J. Lambert, Peter F. Buckley

Producción científica: Articlerevisión exhaustiva

9 Citas (Scopus)


In the presentation "Switching and Metabolic Syndrome," Weiden summarizes reasons to switch antipsychotics, highlighting weight gain and other metabolic adverse events as recent treatment targets. In "Texas Medication Algorithm Project (TMAP)," Miller reviews the TMAP study design, discusses results related to the algorithm versus treatment as usual, and concludes with the implications of the study. Lambert's presentation, "Dosing and Titration Strategies to Optimize Patient Outcome When Switching Antipsychotic Therapy," reviews the decision-making process when switching patients' medication, addresses dosing and titration strategies to effectively transition between medications, and examines other factors to consider when switching pharmacotherapy.

Idioma originalEnglish (US)
Páginas (desde-hasta)e02
PublicaciónThe Journal of clinical psychiatry
EstadoPublished - ene 2007
Publicado de forma externa

ASJC Scopus subject areas

  • Psychiatry and Mental health


Profundice en los temas de investigación de 'The art and science of switching antipsychotic medications, part 2.'. En conjunto forman una huella única.

Citar esto